0.00Open0.02Pre Close0 Volume42 Open Interest705.00Strike Price0.00Turnover2691.66%IV7.86%PremiumJan 3, 2025Expiry Date0.00Intrinsic Value100Multiplier-2DDays to Expiry0.02Extrinsic Value100Contract SizeAmericanOptions Type-0.0023Delta0.0003Gamma38255.00Leverage Ratio-128.0625Theta0.0000Rho-89.01Eff Leverage0.0001Vega
Eli Lilly and Co Stock Discussion
US FDA: Revoked Emergency Use Authorization for GSK and Vir Biotechnology's Sotrovimab as of Dec 13 - Website
$Eli Lilly and Co (LLY.US)$
$Eli Lilly and Co (LLY.US)$
No comment yet